Network pharmacology-based assessment to elucidate the molecular mechanism of anti-diabetic action of Tinospora cordifolia

Abstract

Background: Tinospora cordifolia is used traditionally for the treatment of diabetes and is used in various formulations. Scientific evidence is also available for its anti-diabetic potency under various animal models. However, the probable molecular mechanism of Tinospora cordifolia in the treatment of diabetes has not been illuminated yet. Hence, the present study dealt to elucidate the probable molecular mechanism of anti-diabetic effect of Tinospora cordifolia using network pharmacology approach. Methods: The structural information of bioactive phytoconstituents was retrieved from different open source databases. Compounds were then predicted for their hits with the probable targets involved in the diabetes mellitus. Phytoconstituents were also predicted for their druglikeness score, probable side effects, and ADMET profile. The modulated protein pathways were identified by using the Kyoto Encyclopedia of Genes and Genomes pathway analysis. The interaction between the compounds, proteins, and pathways was interpreted based on the edge count. The docking study was performed using Autodock4.0. Results: Nine phytoconstituents from Tinospora cordifolia were identified to modulate the pathogenic protein molecules involved in diabetes mellitus. Among them, tembetarine scored highest druglikeness hit and had the maximum interaction with proteins involved in diabetes. Further, neuroactive ligand-receptor interaction was predicted as majorly modulated pathway. Conclusion: The current study identified an important antidiabetic constituent, tembetarine which modulated the majority of diabetic proteins majorly modulating neuroactive ligand-receptor interaction.

Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19

“…Due to the complex composition of multiple phytoconstituents from all these medicinal plants, the mixture of this combination could modulate multiple proteins and would help to boost the immune system which can be explained via network pharmacology and gene-set enrichment analysis. Network pharmacology and gene set enrichment analysis are well-accepted approaches to identify the disease target, lead hit molecules and modulated pathways via "multiple component-protein interactions" [9][10][11].…”

Withanolides from Withania somnifera as an immune booster and their therapeutic option against COVID-19

“…Previously, it has been demonstrated that how a single compound can modulate multiple proteins and regulate numerous pathways via the concept of gene-set enrichment analysis and network pharmacology approach [27][28][29][30]. The same principle can be applied via the "multi compound-multi protein" interaction in COVID-19 management.…”

Improvements in HOMA Indices and Pancreatic Endocrinal Tissues in Type -2 Diabetic Rats by DPP-4 Inhibition and Antioxidant Potential of an Ethanol Fruit Extract of Withania Coagulans

“…Binding energy is evidence of the degree of positive interaction that occurs between a target molecule, such as an enzyme, and the test compound or ligand. It is also a measure of the compatibility between a compound and its intended target (Khanal et al 2019;Meduru et al 2016). Sitoindoside IX and most of the other phytocompounds present in the fruit extract exhibited an ideal pro le in the ADMET (Absorption, distribution, metabolism, excretion and toxicity) analysis, which indicates that the compound meets the ve requirements of the Lipinski rule which is a measure of the bioavailability of a molecule and its ability to pass through the blood brain barrier (Lin et al 2015;Patel et al 2017).…”